New eye injection could stop vision loss from herpes infection
NCT ID NCT07329686
First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 19 times
Summary
This study tests a new way to deliver anti-VEGF drugs directly into the cornea to treat abnormal blood vessel growth caused by herpes simplex keratitis. The approach aims to be more targeted and longer-lasting than current treatments. About 100 adults who have not had prior anti-VEGF treatment or corneal surgery will participate. The study will measure changes in blood vessel area, corneal clarity, vision, and eye redness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES SIMPLEX KERATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
1 Xihu Avenue, Shangcheng District,Hangzhou, Zhejiang,China,Hangzhou, Zhejiang Completed
RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.